Ziehm Imaging Americas and Carestream Announce Partnership To Distribute the Ziehm Vision RFD

ROCHESTER, N.Y. & SCOTTSDALE, AZ, April 19 — In partnership with Ziehm Imaging, Carestream Health is pleased to announce the addition of a mobile C-arm into its growing innovative product portfolio. Known as the Ziehm Vision RFD C-arm, this surgical imaging system will further enhance Carestream’s mobile and fluoroscopic product offerings to benefit even more healthcare providers. The system will be available in the U.S. and Canada in 2021. 

The Vision RFD C-arm offers a 25kw generator, in either a 20.5 x 20.5 cm or 31 x 31 cm field of view flat-panel CMOS digital detector, allowing for broad procedural work including vascular, cardiac, spine ortho-trauma and pain management, in addition to many general surgical applications. The system’s Advanced Active Cooling enables extended case times beyond traditional air-cooled systems. It also provides an intuitive graphical interface that benefits technologists with reduced training time as well as improved productivity.

“The partnership with Carestream confirms Ziehm Imaging’s industry-leading technology,” said Nelson Mendes, President and CEO of Orthoscan and Ziehm Imaging Inc. “As a result of this partnership, we're able to provide Carestream and its customers with one of the most innovative C-arms on the market. The Ziehm Vision RFD delivers advanced surgical care with the Ziehm Usability Concept, provides exceptional image quality and helps to reduce exposure significantly with the next-generation SmartDose, thereby providing a very unique package.”

Ziehm Vision RFD systems will be available for sale and service through Carestream. The company’s Sales & Service team—working in collaboration with Ziehm Imaging—will provide responsive support to all valued customers. Carestream Service is widely recognized for its outstanding customer satisfaction and prompt support.

“The addition of the Ziehm C-arm to our medical imaging portfolio—backed by Carestream’s deep experience in radiology and fluoroscopy applications—is another example of our commitment to meet the evolving needs of our customers and their patients,” said Steve Romocki, Worldwide Product Line Manager for Radiology Systems at Carestream.

###

 

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.